Neumora plans clinical trials, data readouts through 2026
Go back to Neumora plans clinical trials, data readouts through 2026| (NASDAQ: NMRA) | Delayed: 1.66 +0.17 (11.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.49 | 52 Week High | $ | |||
| Open | $1.51 | 52 Week Low | $ | |||
| Day High | $1.71 | P/E | N/A | |||
| Day Low | $1.50 | EPS | $ | |||
| Volume | 811,304 | |||||

